Emerson Declares Dividend
Get Alerts EMR Hot Sheet
Price: $143.07 +0.69%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.4%
Revenue Growth %: +5.5%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.4%
Revenue Growth %: +5.5%
Join SI Premium – FREE
ST. LOUIS--(BUSINESS WIRE)-- The board of directors of Emerson (NYSE: EMR) today declared the regular quarterly cash dividend of forty-nine cents ($0.49) per share of common stock payable March 11, 2019 to stockholders of record February 15, 2019.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190205005648/en/
Emerson
Casey Murphy (314) 982-6220
Source: Emerson
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein SocGen Group Starts Emerson (EMR) at Outperform
- Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
- Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged P
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share